Adjuvant Chemo-Endocrine Therapy or Endocrine Therapy Alone for Postmenopausal Patients: Ludwig Studies III and IV

This publication has 6 references indexed in Scilit:

• A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
  Journal of Clinical Oncology, 1986
• The Christie Hospital Tamoxifen (Nolvadex) adjuvant trial for operable breast carcinoma - 7-yr results
  European Journal of Cancer and Clinical Oncology, 1985
• BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUES
  The Lancet, 1985
• Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1982
• 1-Phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer.Lack of association of disease-free survival with depression of ovarian function
  Cancer, 1979
• The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug tolerance
  Cancer, 1977